Sign In
Buy SILK
$27.49
+0 (+0%)
At Close: Dec 13, 2024
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
12:30pm, Monday, 02'nd May 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that
Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference
04:10pm, Tuesday, 26'th Apr 2022
SUNNYVALE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company w
Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022
08:15pm, Wednesday, 13'th Apr 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will rep
Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022
04:15pm, Wednesday, 13'th Apr 2022
SUNNYVALE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will repor
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
Silk Road Medical, Inc (SILK) CEO Erica Rogers on Q4 2021 Results - Earnings Call Transcript
12:01pm, Sunday, 27'th Feb 2022
Silk Road Medical, Inc (SILK) CEO Erica Rogers on Q4 2021 Results - Earnings Call Transcript
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
10:40pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook
09:01pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial res
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
07:15pm, Thursday, 24'th Feb 2022
Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
01:06pm, Sunday, 20'th Feb 2022 Benzinga
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
On the regulatory front, the Food and Drug A
Silk Road Medical (SILK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
08:03pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
09:30pm, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will repo
Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
04:30pm, Thursday, 03'rd Feb 2022
SUNNYVALE, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report
Silk Road Medical to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09:30pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
SUNNYVALE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company
